Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin

Next
Next

Lennham publishes manuscript detailing the nonclinical PK and safety evaluation of d9-caffeine in Food and Chemical Toxicology